Back to Journals » OncoTargets and Therapy » Volume 15
Case report
FGFR2-ERC1: A Subtype of FGFR2 Oncogenic Fusion Variant in Lung Adenocarcinoma and the Response to Anlotinib
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
5,108 | Dovepress* | 4,817+ | 251 | 5,068 | |
PubMed Central* | 291 | 71 | 362 | ||
Totals | 5,108 | 322 | 5,430 | ||
*Since 10 June 2022 |
View citations on PubMed Central and Google Scholar